Grand Pharmaceutical Group (HKSE:00512) Accounts Payable & Accrued Expense : HK$1,831 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Grand Pharmaceutical Group Accounts Payable & Accrued Expense?

Grand Pharmaceutical Group's quarterly accounts payable & accrued expense increased from Dec. 2022 (HK$1,366 Mil) to Jun. 2023 (HK$1,395 Mil) and increased from Jun. 2023 (HK$1,395 Mil) to Dec. 2023 (HK$1,831 Mil).

Grand Pharmaceutical Group's annual accounts payable & accrued expense increased from Dec. 2021 (HK$1,290 Mil) to Dec. 2022 (HK$1,366 Mil) and increased from Dec. 2022 (HK$1,366 Mil) to Dec. 2023 (HK$1,831 Mil).

Grand Pharmaceutical Group Accounts Payable & Accrued Expense Historical Data

The historical data trend for Grand Pharmaceutical Group's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Pharmaceutical Group Accounts Payable & Accrued Expense Chart

Grand Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,162.47

1,137.36

1,289.96

1,365.80

1,831.39

Grand Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,289.96	1,871.71	1,365.80	1,395.01	1,831.39

Grand Pharmaceutical Group Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Grand Pharmaceutical Group (HKSE:00512) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (HKSE:00512) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

MX6A:Germany

Address

99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG

Website

http://www.chinagrandpharm.com

Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.

Executives

Shang Hai Yuan Da Chan Rong Tou Zi Guan Li You Xian Gong Si	2101 Beneficial owner
Hu Kaijun	2201 Interest of corporation controlled by you
East Ocean Capital (hong Kong) Company Limited	2101 Beneficial owner
Lion River I N.v.	2201 Interest of corporation controlled by you
Li Zhenfu	2201 Interest of corporation controlled by you
Gl Partners Capital Management Ltd.	2201 Interest of corporation controlled by you
Assicurazioni Generali Spa	2201 Interest of corporation controlled by you
Citic Group Corporation	2201 Interest of corporation controlled by you
Citic Limited	2201 Interest of corporation controlled by you
China Citic Bank Corporation Limited	2201 Interest of corporation controlled by you
Cncb (hong Kong) Investment Limited	2106 Person having a security interest in shares
Grand (hongkong) International Investments Holdings Limited
Chau Tung
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si
Outwit Investments Limited

Grand Pharmaceutical Group (HKSE:00512) Headlines

No Headlines